Submission Of Notice Of Annual General Meeting To Be Held On September 26, 2018.

• Security Code: 524715
• Company: SUNPHARMA

Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, we are enclosing herewith Notice for the 26th Annual General Meeting of the shareholders of the Company, scheduled to be held on Wednesday, September 26, 2018 at 02.45 p.m. at Crystal Hall, Grand Mercure Vadodara Surya Palace, Opposite Parsi Agyari, Sayajigunj, Vadodara - 390 020, Gujarat, India, (a copy of which is being despatched/emailed to all the shareholders of the Company). The business proposed to be transacted at the 26th Annual General Meeting, as detailed in the Notice, are as follows:

ORDINARY BUSINESS:
1. a. Adoption of audited standalone financial statements of the Company for the financial year ended March 31, 2018 and the reports of the Board of Directors and Auditors thereon
b. Adoption of audited consolidated financial statements of the Company for the financial year ended March 31, 2018 and the report of the Auditors thereon
2. Declaration of dividend on equity shares for the financial year ended March 31, 2018
3. Re-appointment of Mr. Dilip S. Shanghvi (DIN: 00005588), who retires by rotation and being eligible offers himself for re-appointment
4. Re-appointment of Mr. Sudhir V. Valia (DIN: 00005561), who retires by rotation and being eligible offers himself for re-appointment

SPECIAL BUSINESS:
5. Appointment of Mr. Vivek Chaand Sehgal (DIN: 00291126) as Independent Director of the Company
6. Appointment of Mr. Gautam Doshi (DIN: 00004612) as an Independent Director of the Company
7. Special Resolution for re-appointment and remuneration of Mr. Sudhir V. Valia (DIN: 00005561) as Whole-time Director
8. Special Resolution for re-appointment and remuneration of Mr. Sailesh T. Desai (DIN: 00005443) as Whole-time Director
9. Re-appointment of Mr. Kalyanasundaram Subramanian (DIN: 00179072) as Whole-time Director without any remuneration
10. Special Resolution for continuation of Directorship of Mr. Israel Makov (DIN:05299764)
11. Ratification of Remuneration of Cost Auditors of the Company for the financial year 2018-19

This is for your information and record.